61919-621 NDC - IBU ()

Drug Information

Product NDC: 61919-621

Proprietary Name: IBU

Non Proprietary Name:

Active Ingredient(s):


Administration Route(s):

Dosage Form(s):

Pharmacy Class(es):
  • Anti-Inflammatory Agents;
  • Non-Steroidal [CS];
  • Cyclooxygenase Inhibitors [MoA];
  • Nonsteroidal Anti-inflammatory Drug [EPC]

Labeler Information

Labeler Name: Direct _Rx
Product Type:
FDA Application Number:
Marketing Category:
Start Marketing Date:8/20/2019

Package Information

No. Package Code Package Description Billing Unit
161919-621-1515 TABLET in 1 BOTTLE (61919-621-15)EA
261919-621-2121 TABLET in 1 BOTTLE (61919-621-21)EA
361919-621-3030 TABLET in 1 BOTTLE (61919-621-30)EA
461919-621-4040 TABLET in 1 BOTTLE (61919-621-40)EA
561919-621-6060 TABLET in 1 BOTTLE (61919-621-60)EA
661919-621-71100 TABLET in 1 BOTTLE (61919-621-71)EA
761919-621-72120 TABLET in 1 BOTTLE (61919-621-72)EA
861919-621-9090 TABLET in 1 BOTTLE (61919-621-90)EA

NDC Record

Field Name Field Value Definition
PRODUCT NDC61919-621The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAMEIBUThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
START MARKETING DATE8/30/2016This is the date that the labeler indicates was the start of its marketing of the drug product.
LABELER NAMEDIRECT RXName of Company corresponding to the labeler code segment of the Product NDC.
PRODUCT NDC61919-621The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAMEIBUThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
START MARKETING DATE4/30/2019This is the date that the labeler indicates was the start of its marketing of the drug product.
LABELER NAMEDirectRXName of Company corresponding to the labeler code segment of the Product NDC.
PRODUCT NDC61919-621The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAMEIBUThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
START MARKETING DATE12/29/2015This is the date that the labeler indicates was the start of its marketing of the drug product.
LABELER NAMEDirectRXName of Company corresponding to the labeler code segment of the Product NDC.
PRODUCT NDC61919-621The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAMEIBUThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
START MARKETING DATE6/26/2019This is the date that the labeler indicates was the start of its marketing of the drug product.
LABELER NAMEDirect_RxName of Company corresponding to the labeler code segment of the Product NDC.
PRODUCT NDC61919-621The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAMEIBUThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
START MARKETING DATE8/20/2019This is the date that the labeler indicates was the start of its marketing of the drug product.
LABELER NAMEDirect_RxName of Company corresponding to the labeler code segment of the Product NDC.
PRODUCT NDC61919-621The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAMEIBUThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
START MARKETING DATE8/20/2019This is the date that the labeler indicates was the start of its marketing of the drug product.
LABELER NAMEDirect_RxName of Company corresponding to the labeler code segment of the Product NDC.
PRODUCT NDC61919-621The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAMEIBUThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
START MARKETING DATE8/20/2019This is the date that the labeler indicates was the start of its marketing of the drug product.
LABELER NAMEDirect _RxName of Company corresponding to the labeler code segment of the Product NDC.
PRODUCT NDC61919-621The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAMEIBUPROFENThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
START MARKETING DATE8/20/2019This is the date that the labeler indicates was the start of its marketing of the drug product.
LABELER NAMEDirect_RxName of Company corresponding to the labeler code segment of the Product NDC.

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023